| |
|
|
|
Ocular Therapeutix Inc.  
|
|
7.49 0.07 (0.01%) |
07-13 15:12 |
|
Open: |
7.54 |
Pre close: |
7.42 |
Target:
|
9.80 
|
|
High: |
7.72 |
Low: |
7.39 |
Resistance:
|
8.39
9.24
|
|
Volume: |
456,429 |
Market Cap: |
470M |
Support:
|
7.02
5.84
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
7.49
|
MACD |
MACD(12,26):
|
0.01  |
|
MA(20): |
8.24 |
Signal(12,26,9): |
0.19 |
|
MA(100): |
6.30 |
Stochastic Oscillator |
%K(14,3):
|
12.11 |
|
MA(250): |
4.95 |
%D(3): |
11.76 |
|
Average Volume(K) |
3-Month: |
97905
|
52-Week |
High:
|
9.24 |
|
10-Days: |
76235 |
Low: |
2.46 |
|
RSI |
RSI(14):
|
45.80 |
Change(%): |
45.9 |
|
Financials, Statistics and Valuation |
|
EPS |
-1.900 |
Return on Equity (ttm) |
-1211.0 |
Shares Out. (M) |
62.77 |
|
EPS Est. Current Year |
-2.290 |
Return on Assets (ttm) |
-59.3 |
Shares Float (M) |
46.66 |
|
EPS Est. Next Year |
-2.110 |
PEG Ratio |
0.00 |
% Held by Insiders |
9.89 |
|
EPS Est. Next Quarter |
-0.530 |
Qtrly Rev. Growth |
430.3 |
% Held by Institutions |
50.83 |
|
Forward EPS |
-1.910 |
Gross Profit (p.s.) |
-0.624 |
Shares Short (K) |
5620 |
|
Book Value (p.s.) |
-0.200 |
EBITDA (p.s.) |
-1.276 |
P/E |
-3.98 |
|
Sales Per Share |
0.101 |
Qtrly Earnings Growth |
0.00 |
P/BV |
-37.80 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-77.05 |
P/S |
74.85 |
|
Operating Margin |
-1304.51 |
Levered Free Cash Flow
(M) |
-50.88 |
P/CF |
-6.16 |
|
|
|
|
|
|
